Inhalation Sciences contracts AQ Group to scale up production

Inhalation Sciences (ISAB) and AQ M-Tech AB in Uppsala have entered into an agreement on the production of ISAB products. The contract is an important step in ISAB's commercialization process, creating good conditions for ISAB to meet increased demand for its products.

Recently listed on Stockholm’s AktieTorget, ISAB develops and sells novel lab equipment for inhalation R&D that measures how particles in inhaled air affect our health. The company's main product, PreciseInhale, has been sold to and installed at a total of eight leading companies and academic research institutes, including Astra Zeneca, Chiesi and Fraunhofer. ISAB is now entering a phase of increased sales.

AQ M-Tech AB is a part of AQ Group AB. AQ M-Tech specializes in the development, construction and manufacturing of tailored technology solutions and products. AQ M-Tech AB is a medtech company within AQ group specializing in medical products and requirements.

ISAB CEO Fredrik Sjövall: "AQ M-Tech has been involved in producing parts of our products for a long time and we already have a very good relationship. Expanding AQ M-Tech's commitment is an important step in accelerating the commercialization rate of PreciseInhale. We expect it to lead to lower production costs and increased margins. AQ M-Tech has all the qualities we’d wish for in a production partner, with deep expertise in mechanics, electronics and advanced assembly."

AQ M-Tech’s CEO Tobias Hammar: ”We’re proud and delighted ISAB has chosen us as a supplier. ISAB’s products fit well with our strategy of being a production partner in the field of advanced medical products.”

For more information about Inhalation Sciences please contact:

Fredrik Sjövall, CEO 
Email: fredrik.sjovall@inhalation.se
Phone: +46 (0)70 64 508 75

About Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments for research into inhalation. The company’s patented lab instrument, PreciseInhale®, enables researchers to characterize, with high precision, how aerosols and small particles impact our lungs, and so our health, when we breathe them in.

About AQ Group

AQ Group is a leading supplier to demanding industrial customers and is listed on Nasdaq, Stockholm's main market. The Group consists mainly of operating companies that each develop special skills and, in cooperation with other companies, strive to offer cost-effective solutions in close cooperation with their customers. The Group’s is located in Västerås, Sweden, and by December 31 2016 had approx. 5,100 employees in Sweden, Bulgaria, Estonia, India, China, Lithuania, Mexico, Poland, Italy, Thailand, Hungary and Serbia. By 2016, AQ’s turnover was approx. 3.3 BSEK, and since the Group started in 1994 it has reported positive earnings every quarter. AQ Group has the highest credit rating, AAA, according to Bisnode.

The information above was provided by Inhalation Sciences Sweden AB (publ) according to EU Market Abuse Regulations. The information was provided, through the above contact person, for publication on October 5, 2017.

About Us

Inhalation Sciences Sweden AB (publ.) develops and sells patented, highly innovative labtech equipment for inhalation research. Scientists using it can now know, with unprecedented accuracy, how particles behave in our lungs when we inhale them: whether new pollutants or life-saving drugs that power human development.

Subscribe

Documents & Links